Deep Learning-based Approach for Automated Assessment of Interstitial Lung Disease in Systemic Sclerosis on CT Images
- PMID: 33937829
- PMCID: PMC8082359
- DOI: 10.1148/ryai.2020190006
Deep Learning-based Approach for Automated Assessment of Interstitial Lung Disease in Systemic Sclerosis on CT Images
Abstract
Purpose: To develop a deep learning algorithm for the automatic assessment of the extent of systemic sclerosis (SSc)-related interstitial lung disease (ILD) on chest CT images.
Materials and methods: This retrospective study included 208 patients with SSc (median age, 57 years; 167 women) evaluated between January 2009 and October 2017. A multicomponent deep neural network (AtlasNet) was trained on 6888 fully annotated CT images (80% for training and 20% for validation) from 17 patients with no, mild, or severe lung disease. The model was tested on a dataset of 400 images from another 20 patients, independently partially annotated by three radiologist readers. The ILD contours from the three readers and the deep learning neural network were compared by using the Dice similarity coefficient (DSC). The correlation between disease extent obtained from the deep learning algorithm and that obtained by using pulmonary function tests (PFTs) was then evaluated in the remaining 171 patients and in an external validation dataset of 31 patients based on the analysis of all slices of the chest CT scan. The Spearman rank correlation coefficient (ρ) was calculated to evaluate the correlation between disease extent and PFT results.
Results: The median DSCs between the readers and the deep learning ILD contours ranged from 0.74 to 0.75, whereas the median DSCs between contours from radiologists ranged from 0.68 to 0.71. The disease extent obtained from the algorithm, by analyzing the whole CT scan, correlated with the diffusion lung capacity for carbon monoxide, total lung capacity, and forced vital capacity (ρ = -0.76, -0.70, and -0.62, respectively; P < .001 for all) in the dataset for the correlation with PFT results. The disease extents correlated with diffusion lung capacity for carbon monoxide, total lung capacity, and forced vital capacity were ρ = -0.65, -0.70, and -0.57, respectively, in the external validation dataset (P < .001 for all).
Conclusion: The developed algorithm performed similarly to radiologists for disease-extent contouring, which correlated with pulmonary function to assess CT images from patients with SSc-related ILD.Supplemental material is available for this article.© RSNA, 2020.
2020 by the Radiological Society of North America, Inc.
Conflict of interest statement
Disclosures of Conflicts of Interest: G.C. disclosed no relevant relationships. M.V. disclosed no relevant relationships. A.R. disclosed no relevant relationships. E.I.Z. disclosed no relevant relationships. G.A. disclosed no relevant relationships. C.M. disclosed no relevant relationships. R.M. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed money paid to author for employment from Therapanacea. Other relationships: disclosed no relevant relationships. N. Bus disclosed no relevant relationships. N.J. disclosed no relevant relationships. A.M. disclosed no relevant relationships. T.H.H. disclosed no relevant relationships. L.M.C. disclosed no relevant relationships. N. Benmostefa disclosed no relevant relationships. L.M. disclosed no relevant relationships. A.T.D.X. disclosed no relevant relationships. N.P. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed money paid to author for consultancy from Safran, employment from Therapanacea, and royalties from Intrasense; disclosed patents issued from Ecole Centrale Supelec; patents licensed from Intrasence, Therapanacea, and Olea; and royalties from Intrasense, Therapanacea, and Olea. Other relationships: disclosed no relevant relationships. M.P.R. disclosed no relevant relationships.
Figures
References
-
- Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008;37(4):223–235. - PubMed
-
- LeRoy EC, Black C, Fleischmajer R, et al. . Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15(2):202–205. - PubMed
-
- Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 2014;44(2):208–219. - PubMed
-
- Tyndall AJ, Bannert B, Vonk M, et al. . Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69(10):1809–1815. - PubMed
-
- Meier FMP, Frommer KW, Dinser R, et al. . Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012;71(8):1355–1360. - PubMed
LinkOut - more resources
Full Text Sources
